Suppr超能文献

心肌肌钙蛋白 I 与肌酸激酶同工酶-MB 对心脏磁共振评估梗死面积的预测价值比较。

Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.

机构信息

Cardiology Unit, Cardiopulmonary Science Department, Azienda Ospedaliero-Universitaria, Udine, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):587-92. doi: 10.2459/JCM.0b013e3283383153.

Abstract

BACKGROUND

The estimation of infarct size by biochemical myocardial necrosis markers is used in current clinical practice, rather than the more expensive and not always available imaging techniques. However, for this purpose, the peak value of serum biomarkers can overestimate the necrotic area, especially after reperfusion.

OBJECTIVE

We investigated whether late release cardiac troponin I (cTnI) values could predict more precisely infarct volume measured by delayed-enhancement cardiac magnetic resonance (DE-CMR) in patients with acute myocardial infarction [ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI)] independently of reperfusion (spontaneous and provoked).

METHODS

Sixty patients with a first acute myocardial infarction (55 STEMI and five NSTEMI) and normal function were enrolled. Among STEMI patients, 52 underwent reperfusion. cTnI and creatine kinase-myocardial band were assessed at admission and at 6, 12, 24, 48, 72 and 96 h (+/-1 h) from symptom onset. DE-CMR (Siemens Avanto 1.5T) was performed before discharge (4 +/- 2 days). Infarct size was determined by manual delineation of the areas of delayed enhancement. Infarct volume was calculated as the sum of each slice of infarct size area multiplied by thickness.

RESULTS

Peak cTnI was 55 +/- 59 ng/ml (range 0.3-347). The area under the curve of cTnI was 1916 +/- 2224 ng/ml. The volume of infarcted myocardium assessed by DE-CMR was 27 +/- 25 ml (range 0-134). The single value of cTnI at 72 h after symptom onset provided the most accurate estimation of predischarge infarct volume (r = 0.84, 95% confidence interval 0.75-0.91) and was significantly more accurate than creatine kinase-myocardial band value assessed at any time during the same period (r = 0.42, 95% confidence interval 0.19-0.62; P < 0.002).

CONCLUSION

In patients with a first acute myocardial infarction, cTnI value assessed at 72 h from symptom onset shows the best correlation with predischarge infarct volume as assessed by DE-CMR and is superior to cTnI and creatine kinase-myocardial band peak and total values.

摘要

背景

目前的临床实践中,通过生化心肌坏死标志物来估计梗死面积,而不是使用更昂贵且并非总是可用的成像技术。然而,对于这种目的,血清生物标志物的峰值可能会高估坏死面积,尤其是在再灌注后。

目的

我们研究了在急性心肌梗死(ST 段抬高型心肌梗死 [STEMI] 和非 ST 段抬高型心肌梗死 [NSTEMI])患者中,迟发性增强心脏磁共振(DE-CMR)测量的梗死体积是否可以通过晚期心脏肌钙蛋白 I(cTnI)值更准确地预测,而与再灌注(自发性和诱发)无关。

方法

共纳入 60 例首次急性心肌梗死(55 例 STEMI 和 5 例 NSTEMI)且心功能正常的患者。在 STEMI 患者中,有 52 例接受了再灌注治疗。在症状发作后 6、12、24、48、72 和 96 小时(+/-1 小时)时检测 cTnI 和肌酸激酶-MB。在出院前(4+/-2 天)进行 DE-CMR(西门子 Avanto 1.5T)检查。通过手动描绘延迟增强区域来确定梗死面积。通过将每个梗死面积区域的切片乘以厚度来计算梗死体积。

结果

峰值 cTnI 为 55+/-59ng/ml(范围 0.3-347)。cTnI 的曲线下面积为 1916+/-2224ng/ml。通过 DE-CMR 评估的梗死心肌体积为 27+/-25ml(范围 0-134)。症状发作后 72 小时的单个 cTnI 值可最准确地预测出院前的梗死体积(r=0.84,95%置信区间 0.75-0.91),明显优于同期任何时间点评估的肌酸激酶-MB 值(r=0.42,95%置信区间 0.19-0.62;P<0.002)。

结论

在首次急性心肌梗死患者中,症状发作后 72 小时评估的 cTnI 值与 DE-CMR 评估的出院前梗死体积相关性最好,优于 cTnI 和肌酸激酶-MB 的峰值和总水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验